CASE REPORT {#omy124s1}
===========

A 61-year-old female presented with complaints of fatigue, exertional shortness of breath, hemoptysis and intermittent hematuria for 1 month. Vitals signs were unremarkable. Chest examination revealed decreased air entry with basal crackles and abdomen was distended and positive for ascites with 1+ pitting edema. Investigations showed elevated creatinine at 6.7 (Ref: 0.5--1.1 mg/dl), blood urea nitrogen of 61 (Ref: 6--20 mg/dl), normal liver function tests with albumin of 3.4 (Ref: 3.4--4.8 g/dl) and negative hepatitis panel (A--C). Urinalysis showed 4+ protein, 3+ blood with no nitrite/leukocyte esterase. Bence Jones Protein was negative by electrophoresis. She also had negative antinuclear antibodies, ant-neutrophilic cytoplasmic antibody (p- and c-ANCA), anti-double stranded DNA and normal total complement (C3 and C4), which were reported within 2 days of admission. Her anti-GBM was negative using both enzyme-linked immunosorbent assay and indirect immunofluorescence and was performed twice, 2 weeks apart (results were available on days 3 and 18 from admission, respectively). She underwent renal biopsy on day 4 of admission and the result was positive for crescentic glomerulonephritis with segmental scars and fibrous crescents (reported on day 19; Fig. [1](#omy124F1){ref-type="fig"}a). Immunofluorescence was positive for linear IgG staining, which is consistent with anti-GBM glomerulonephritis (Fig. [1](#omy124F1){ref-type="fig"}b). She was started on plasmapheresis and corticosteroids on day 21 of admission. However, no significant improvement of her symptoms, serum creatinine or urine output was achieved after six cycles of plasmapheresis and, therefore, she was started on hemodialysis.

![Glomerulus with a fibrocellular cresent (A) and immunofluorescence showing linear pattern IgG (B).](omy124f01){#omy124F1}

DISCUSSION {#omy124s2}
==========

Goodpasture's disease, first described by Ernest Goodpasture in 1919 \[[@omy124C1]\], is rare autoimmune disease characterized by autoantibodies mostly directed against the alpha3 chain of type IV non-collagenous domain in the lung and kidneys \[[@omy124C2]\]. It typically presents as rapidly progressive crescentic glomerulonephritis and/or pulmonary hemorrhage \[[@omy124C3]\]. Although more than 90% of patients have detectable anti-GBM antibodies, there are few cases reported of negative circulating anti-GBM with negative ANCA \[[@omy124C4]\]. Therefore, the diagnosis requires the demonstration of linear immunofluorescent deposits along the glomerular and/or alveolar basement membranes \[[@omy124C3]\]. Successful management is largely dependent on the clinical presentation, biochemical level and histopathological features. Nevertheless, the rationale behind medical therapy is to eliminate the circulating antibodies (plasmapheresis) and to suppress the production of the anti-GBM antibodies (cyclophosphamide and corticosteroids) \[[@omy124C5]\].
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